Rilematovir

DRUG3 trials

Sponsors

Janssen Research & Development, LLC

Conditions

HealthyRespiratory Syncytial VirusRespiratory Tract Infections

Phase 1

A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir

CompletedNCT05155007

Janssen Research & Development, LLCHealthy

Start: 2021-12-10End: 2022-02-04Updated: 2025-02-03

Phase 2

A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection

TerminatedNCT04978337

Janssen Research & Development, LLCRespiratory Syncytial Virus

Start: 2021-11-17End: 2022-03-31Updated: 2024-09-24

Phase 3

A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

TerminatedNCT04583280

Janssen Research & Development, LLCRespiratory Tract Infections

Start: 2021-09-06End: 2022-03-18Updated: 2025-02-04